Journal of Alzheimer's disease : JADHumansAlzheimer DiseaseDouble-Blind MethodMaleFemale
A randomized clinical trial of low-dose cannabis extract in Alzheimer's disease.
Rafael de Morais Cury, Taynara da Silva, Fernando Cezar-Dos-Santos, Yasmin Rafaela Correia Fakih, Karlin Andrea Ramírez Narvaez, Murilo Chaves Gouvea, Carlos Espínola, Charles Francisco Ferreira, Wagner Antonio Chiba de Castro, Fabrício Alano Pamplona, Elton Gomes da Silva, Maíra Assunção Bicca, Francisney Pinto Nascimento
Published: 202510.1177/13872877251389608
Abstract
BackgroundPreclinical and clinical evidence suggest that low-dose cannabinoids could ameliorate Alzheimer's disease (AD) signs and symptoms. We designed this trial to evaluate the safety and efficacy of low-dose THC-CBD balanced cannabinoid extract i…
Preview only. Read the full abstract at the source